Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac (2017)
- Authors:
- USP affiliated authors: ROCHA, ADRIANA - FCFRP ; TOZATTO, EDUARDO - FCFRP ; DONADI, EDUARDO ANTONIO - FMRP ; LANCHOTE, VERA LUCIA - FCFRP
- Unidades: FCFRP; FMRP
- DOI: 10.1208/s12248-017-0138-9
- Subjects: FARMACODINÂMICA; FARMACOCINÉTICA
- Keywords: Enantiomers; Etodolac; Human clinical trial; Population pharmacokinetics/pharmacodynamics; Translational modeling and simulation approach
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: The AAPS Journal
- ISSN: 1550-7416
- Volume/Número/Paginação/Ano: v. 19, n. 6, p. 1814-1825, 2017
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: other-oa
-
ABNT
SILVA, Carolina de Miranda et al. Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac. The AAPS Journal, v. 19, n. 6, p. 1814-1825, 2017Tradução . . Disponível em: https://doi.org/10.1208/s12248-017-0138-9. Acesso em: 28 dez. 2025. -
APA
Silva, C. de M., Rocha, A., Tozatto, E., Silva, L. M. da, Donadi, E. A., Costa, T. D., et al. (2017). Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac. The AAPS Journal, 19( 6), 1814-1825. doi:10.1208/s12248-017-0138-9 -
NLM
Silva C de M, Rocha A, Tozatto E, Silva LM da, Donadi EA, Costa TD, Lanchote VL, Schmidt S, Bulitta JB. Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac [Internet]. The AAPS Journal. 2017 ; 19( 6): 1814-1825.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1208/s12248-017-0138-9 -
Vancouver
Silva C de M, Rocha A, Tozatto E, Silva LM da, Donadi EA, Costa TD, Lanchote VL, Schmidt S, Bulitta JB. Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac [Internet]. The AAPS Journal. 2017 ; 19( 6): 1814-1825.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1208/s12248-017-0138-9 - Enantioselective analysis of etodolac in human plasma by LC–MS/MS: application to clinical pharmacokinetics
- Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A
- Factors influencing plasma concentrations of carbamazepine, carbama zepine-10,11-epoxide and carbamazepine-10,11-dihydroxy in epileptic children
- A highly sensitive lc-ms-ms assay for analysis of ciclophosphamide enantiomers in plasma: applications to pharmacokinetics in lupus nephritis patients
- Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers
- Desenvolvimento de metodologia analítica por cromatografia gasosa para determinação do teor de cafeína em sementes de guaraná (Paullinia cupana)
- Estereosseletividade na farmacocinética da Fluvastatina em pacientes diabéticos-hipercolesterolêmicos
- Stereoselective pharmacokinetics of lercanidipine by liquid chromatography tandem mass spectrometry
- Omeprazole inhibits preferentially the metabolism of the (+)-(S)-citalopram eutomer in healthy volunteers
- Stereoselective disposition of fenoprofen in plasma and synovial fluid of patients with rheumathoid arthritis
Informações sobre o DOI: 10.1208/s12248-017-0138-9 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
